The Cigna Group$271.10UNH · NYSE
The supplied consensus is Buy across 23 analysts, with a mean price target of $490; low and high consensus targets are not provided, so a supported target cluster or consensus spread cannot be established. Other supplied pages cite 27 analysts and targets of $475.23, while TradingView shows a much wider $287-to-$492 range, underscoring inconsistent data sets and disagreement over valuation. The evidence does not identify the most or least bullish analyst, nor does it document a direction of consensus revisions during this week. The substantive divide is between optimism about lower medical costs, cost controls, government-margin recovery and Optum momentum, and caution over FY2025’s net-income decline and the broad target dispersion.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Morgan Stanley | — | $468 | +12.6% | Jun 30, 2026 | Open the report this row came from |
